|
🐜
|
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
27 auth.
N. Grote Beverborg,
Daniela Später,
R. Knöll,
A. Hidalgo,
S. Yeh,
Z. Elbeck,
Herman H. W. Silljé,
Tim R. Eijgenraam,
H. Siga,
M. Zurek,
M. Palmér,
S. Pehrsson,
Tamsin Albery,
N. Bomer,
M. Hoes,
...
C. Boogerd,
M. Frisk,
E. van Rooij,
S. Damle,
W. Louch,
Qing-Dong Wang,
R. Fritsche-Danielson,
K. Chien,
K. Hansson,
A. Mullick,
R. D. de Boer,
P. van der Meer
|
5 |
2021 |
5
🐜
|
|
🐬
|
Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia–reperfusion in a rat model
J. Grönros,
A. Kiss,
M. Palmér,
C. Jung,
D. Berkowitz,
J. Pernow
|
5 |
2013 |
5
🐬
|
|
🐜
|
Neuregulin-1 Induces Cardiac Hypertrophy and Impairs Cardiac Performance in Post-Myocardial Infarction Rats.
7 auth.
M. Zurek,
E. Johansson,
M. Palmér,
Tamsin Albery,
Karin Johansson,
K. Rydén-Markinhutha,
...
Qing-Dong Wang
|
3 |
2020 |
3
🐜
|
|
🐜
|
Cardiac-Specific Overexpression of Oxytocin Receptor Leads to Cardiomyopathy in Mice.
17 auth.
C. Jung,
B. Wernly,
Mikael Bjursell,
J. Wiseman,
Therése Admyre,
J. Wikström,
M. Palmér,
F. Seeliger,
M. Lichtenauer,
M. Franz,
...
Charlotte Frick,
A. Andersson,
M. Elg,
J. Pernow,
P. Sjöquist,
M. Bohlooly-y,
Qing-Dong Wang
|
3 |
2018 |
3
🐜
|
|
🐢
|
Evaluation of systemic exposure of nanoparticle suspensions subcutaneously administered to mice regarding stabilization, volume, location, concentration and size
K. Sigfridsson,
M. Palmér
|
2 |
2014 |
2
🐢
|
|
🐜
|
P6348Phospholamban antisense oligonucleotides drive the reversal of cardiac dysfunction and multiple heart failure parameters during murine dilated cardiomyopathy
14 auth.
D. Spaeter,
A. Gonzalez,
Z. Elbeck,
S. Yeh,
H. Siga,
S. Damle,
M. Palmér,
C. Kuo,
Qing-Dong Wang,
K. Chien,
...
R. Fritsche-Danielson,
K. Hansson,
A. Mullick,
R. Knoell
|
1 |
2019 |
1
🐜
|
